Oxymetholone 50 - Genetic Pharmaceuticals

Oxymetholone, introduced as Anadrol-50 in the early 1960s by Syntex, was initially intended to treat muscle wasting, anemia, and osteoporosis. Its powerful anabolic effect stems from its structural modification of dihydrotestosterone, which includes a 2-hydroxymethylene group and 17α-alkylation for oral activity. Despite being a DHT derivative, it produces estrogen-like side effects such as water retention. Due to hepatotoxicity and cardiovascular strain, its clinical use today is limited to tightly controlled settings.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Oxymetholone 50 by Genetic Pharmaceuticals, consult with your doctor or healthcare professional.